mercaptopurine and Histiocytic-Sarcoma

mercaptopurine has been researched along with Histiocytic-Sarcoma* in 2 studies

Other Studies

2 other study(ies) available for mercaptopurine and Histiocytic-Sarcoma

Article	Year
Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia. Blood, 2016, 11-17, Volume: 128, Issue:20 Topics: Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Female; GTP Phosphohydrolases; Histiocytic Sarcoma; Humans; Membrane Proteins; Mercaptopurine; Methotrexate; Mutation, Missense; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Suppressor Protein p53; Vincristine	2016
Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy. Pediatric blood & cancer, 2014, Volume: 61, Issue:10 Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditionally been poor. There is currently no consensus on the optimal management of these tumors, with the literature consisting largely of case reports and small case series utilizing a wide variety of therapies. We describe a case of HS in an 8-year-old female who was successfully treated with an abbreviated leukemia chemotherapy regimen. Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Histiocytic Sarcoma; Humans; Mercaptopurine; Methotrexate; Prednisone; Risk Factors; Vincristine	2014

Article

Year

Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.

Blood, 2016, 11-17, Volume: 128, Issue:20

Topics: Adult; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Female; GTP Phosphohydrolases; Histiocytic Sarcoma; Humans; Membrane Proteins; Mercaptopurine; Methotrexate; Mutation, Missense; Neoplasms, Second Primary; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Tumor Suppressor Protein p53; Vincristine

2016

Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.

Pediatric blood & cancer, 2014, Volume: 61, Issue:10

Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditionally been poor. There is currently no consensus on the optimal management of these tumors, with the literature consisting largely of case reports and small case series utilizing a wide variety of therapies. We describe a case of HS in an 8-year-old female who was successfully treated with an abbreviated leukemia chemotherapy regimen.

Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Histiocytic Sarcoma; Humans; Mercaptopurine; Methotrexate; Prednisone; Risk Factors; Vincristine

2014